Product Code: GVR-4-68040-322-2
Plaque Modification And Removal Devices Market Growth & Trends:
The global plaque modification and removal devices market size is expected to reach USD 3.26 billion by 2030, exhibiting a CAGR of 8.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The global market for plaque modification and removal devices is experiencing robust growth, fueled by technological innovations, increasing prevalence of cardiovascular diseases, and favorable reimbursement policies. Moreover, the rising incidence of cardiovascular diseases, particularly among the aging population, underscores the critical need for effective plaque modification and removal devices. With greater awareness of cardiovascular health and improved diagnostic techniques, there is an increasing emphasis on early detection and intervention, further driving market demand.
Moreover, supportive government policies and increased healthcare expenditure in emerging economies provide a conducive environment for market expansion. Governments in these regions are investing heavily in healthcare infrastructure and making concerted efforts to improve access to advanced medical treatments. This financial backing not only aids in the procurement of sophisticated medical devices but also supports training programs for healthcare providers, ensuring the effective utilization of these technologies. Moreover, the growing trend of minimally invasive surgeries, which offer reduced recovery times and lower risk of complications, is driving the preference for advanced plaque modification and removal technologies. These surgeries are less traumatic for patients and allow for a quicker return to normal activities, making them highly attractive options. Collectively, these factors contribute to a robust growth trajectory for the plaque modification and removal devices market.
Plaque Modification And Removal Devices Market Report Highlights:
- Based on the product, the atherectomy devices segment accounted for the largest market share of 32.48% in 2023. These devices address the limitations of balloon angioplasty which is driving the segment growth.
- Based on the application, the coronary artery disease segment accounted for the largest market share of 59.83% in 2023 driven by the increasing cases of atherosclerosis, and diabetes.
- Based on the end use, the hospitals segment accounted for the largest market share of 74.23% in 2023 attributed to patient care and safety.
- In 2023, North America dominated with a share of 43.69% due to the rising prevalence of chronic diseases, rapid adoption of technological advancements, and rising elderly population.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1 Segment Definitions
- 1.1.2. Product
- 1.1.3. Application
- 1.1.4. End use
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecasts timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. End Use outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
Chapter 3. Plaque Modification and Removal Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Plaque Modification and Removal Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
Chapter 4. Plaque Modification and Removal Devices Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Plaque Modification and Removal Devices Market: Product Movement Analysis
- 4.3. Plaque Modification and Removal Devices Market by Product Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5. Atherectomy Devices
- 4.5.1. Atherectomy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Thrombectomy Devices
- 4.6.1. Thrombectomy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7. Chronic Total Occlusion Devices
- 4.7.1. Chronic Total Occlusion Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.8. Embolic Protection Devices
- 4.8.1. Embolic Protection Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Plaque Modification and Removal Devices Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Plaque Modification and Removal Devices Market: Application Movement Analysis
- 5.3. Plaque Modification and Removal Devices Market by Application Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. Coronary Artery Disease
- 5.5.1. Coronary Artery Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Peripheral Artery Disease
- 5.6.1. Peripheral Artery Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Plaque Modification and Removal Devices Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Plaque Modification and Removal Devices Market: End Use Movement Analysis
- 6.3. Plaque Modification and Removal Devices Market by End Use Outlook (USD Million)
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5. Hospitals
- 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Ambulatory and Surgical Centers
- 6.6.1. Ambulatory and Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Others
- 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Plaque Modification and Removal Devices Market: Regional Estimates & Trend Analysis
- 7.1. Regional Dashboard
- 7.2. Regional Plaque Modification and Removal Devices Market movement analysis
- 7.3. Plaque Modification and Removal Devices Market: Regional Estimates & Trend Analysis by Technology & End Use
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.5. North America
- 7.5.1. North America Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Reimbursement scenario
- 7.5.2.5. U.S. Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Canada
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Reimbursement scenario
- 7.5.3.5. Canada Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. Europe
- 7.5.5. Europe Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. UK
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Competitive Scenario
- 7.5.6.3. Regulatory Framework
- 7.5.6.4. Reimbursement scenario
- 7.5.6.5. UK Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Germany
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. Reimbursement scenario
- 7.5.7.5. Germany Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.8. France
- 7.5.8.1. Key Country Dynamics
- 7.5.8.2. Competitive Scenario
- 7.5.8.3. Regulatory Framework
- 7.5.8.4. Reimbursement scenario
- 7.5.8.5. France Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.9. Italy
- 7.5.9.1. Key Country Dynamics
- 7.5.9.2. Competitive Scenario
- 7.5.9.3. Regulatory Framework
- 7.5.9.4. Reimbursement scenario
- 7.5.9.5. Italy Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.10. Spain
- 7.5.10.1. Key Country Dynamics
- 7.5.10.2. Competitive Scenario
- 7.5.10.3. Regulatory Framework
- 7.5.10.4. Reimbursement scenario
- 7.5.10.5. Spain Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.11. Denmark
- 7.5.11.1. Key Country Dynamics
- 7.5.11.2. Competitive Scenario
- 7.5.11.3. Regulatory Framework
- 7.5.11.4. Reimbursement scenario
- 7.5.11.5. Denmark Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.12. Sweden
- 7.5.12.1. Key Country Dynamics
- 7.5.12.2. Competitive Scenario
- 7.5.12.3. Regulatory Framework
- 7.5.12.4. Reimbursement scenario
- 7.5.12.5. Sweden Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.13. Norway
- 7.5.13.1. Key Country Dynamics
- 7.5.13.2. Competitive Scenario
- 7.5.13.3. Regulatory Framework
- 7.5.13.4. Reimbursement scenario
- 7.5.13.5. Norway Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Asia Pacific Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Japan
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Reimbursement scenario
- 7.6.2.5. Japan ProductMarket Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. China
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Reimbursement scenario
- 7.6.3.5. China Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. India
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. Reimbursement scenario
- 7.6.4.5. India Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. South Korea
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Reimbursement scenario
- 7.6.5.5. South Korea Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.6. Australia
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Competitive Scenario
- 7.6.6.3. Regulatory Framework
- 7.6.6.4. Reimbursement scenario
- 7.6.6.5. Australia Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.7. Thailand
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Competitive Scenario
- 7.6.7.3. Regulatory Framework
- 7.6.7.4. Reimbursement scenario
- 7.6.7.5. Thailand Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7. Latin America
- 7.7.1. Latin America Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Brazil
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. Reimbursement scenario
- 7.7.2.5. Brazil Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Mexico
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Reimbursement scenario
- 7.7.3.5. Mexico Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.4. Argentina
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. Reimbursement scenario
- 7.7.4.5. Argentina Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8. Middle East & Africa
- 7.8.1. Middle East & Africa Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.2. South Africa
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Competitive Scenario
- 7.8.2.3. Regulatory Framework
- 7.8.2.4. Reimbursement scenario
- 7.8.2.5. South Africa Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Saudi Arabia
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Competitive Scenario
- 7.8.3.3. Regulatory Framework
- 7.8.3.4. Reimbursement scenario
- 7.8.3.5. Saudi Arabia Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.4. UAE
- 7.8.4.1. Key Country Dynamics
- 7.8.4.2. Competitive Scenario
- 7.8.4.3. Regulatory Framework
- 7.8.4.4. Reimbursement scenario
- 7.8.4.5. UAE Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.5. Kuwait
- 7.8.5.1. Key Country Dynamics
- 7.8.5.2. Competitive Scenario
- 7.8.5.3. Regulatory Framework
- 7.8.5.4. Reimbursement scenario
- 7.8.5.5. Kuwait Plaque Modification and Removal Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Market Participant Categorization
- 8.2. Key Company Profiles
- 8.2.1. Boston Scientific Corporation
- 8.2.1.1. Company overview
- 8.2.1.2. Financial performance
- 8.2.1.3. Product benchmarking
- 8.2.1.4. Strategic initiatives
- 8.2.2. Abbott
- 8.2.2.1. Company overview
- 8.2.2.2. Financial performance
- 8.2.2.3. Product benchmarking
- 8.2.2.4. Strategic initiatives
- 8.2.3. Medtronic
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. Becton, Dickinson, and Company
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. Koninklijke Phillips N.V.
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. Stryker
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. AngioDynamics
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives
- 8.2.8. Microvention, Inc.
- 8.2.8.1. Company overview
- 8.2.8.2. Financial performance
- 8.2.8.3. Product benchmarking
- 8.2.8.4. Strategic initiatives
- 8.2.9. Penumbra, Inc.
- 8.2.9.1. Company overview
- 8.2.9.2. Financial performance
- 8.2.9.3. Product benchmarking
- 8.2.9.4. Strategic initiatives
- 8.2.10. REX MEDICAL
- 8.2.10.1. Company overview
- 8.2.10.2. Financial performance
- 8.2.10.3. Product benchmarking
- 8.2.10.4. Strategic initiatives
- 8.2.11. ARGON MEDICAL
- 8.2.11.1. Company overview
- 8.2.11.2. Financial performance
- 8.2.11.3. Product benchmarking
- 8.2.11.4. Strategic initiatives
- 8.2.12. Soundbite Medical Solutions
- 8.2.12.1. Company overview
- 8.2.12.2. Financial performance
- 8.2.12.3. Product benchmarking
- 8.2.12.4. Strategic initiatives